The Cooper Companies, Inc. (LON: 0I3I)

Market Cap	15.42B
Revenue (ttm)	3.03B
Net Income (ttm)	304.78M
Shares Out	n/a
EPS (ttm)	1.52
PE Ratio	50.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	399
Average Volume	4,279
Open	95.32
Previous Close	95.19
Day's Range	95.20 - 96.31
52-Week Range	75.88 - 103.95
Beta	0.99
RSI	55.44
Earnings Date	Mar 6, 2025

About The Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women’s he...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1958
• Employees: 16,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I3I

Financial Performance

In 2024, The Cooper Companies's revenue was $3.90 billion, an increase of 8.41% compared to the previous year's $3.59 billion. Earnings were $392.30 million, an increase of 33.34%.

Financial numbers in USD